Table 2.
Sites of Recurrence According to Initial Stage and Randomized Treatment Regimen (n = 55)
| Randomized Treatment Assignment | Liver | Lung | Liver and Lung | Liver or Lung + Other |
|---|---|---|---|---|
| CFV | ||||
| Stage I | — | 2 | — | 1 |
| Stage III | 9 | 1 | 3 | 2 |
| Stage IV | 11 | 2 | 3 | 1 |
| Total | ||||
| No. | 20 | 5 | 6 | 5 |
| % | 55 | 14 | 17 | 14 |
| CD | ||||
| Stage III | 6 | 1 | 2 | 1 |
| Stage IV | 5 | 2 | 1 | 1 |
| Total | ||||
| No. | 11 | 3 | 3 | 2 |
| % | 58 | 16 | 16 | 10 |
Abbreviations: CFV, cisplatin/fluorouracil/vincristine; CD, cisplatin/doxorubicin.